Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B
- PMID: 23700138
- DOI: 10.1007/s12664-013-0334-1
Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B
Abstract
Background: PON1 is an HDL-associated enzyme having antioxidant activity. PON1 is synthesized in the liver, and there is decreased synthesis of PON1 with increased lipid peroxidation. The study was carried with the aim of establishing whether chronic liver disease (CLD) produced any significant changes in serum arylesterase (AE) and lactonase activities of PON. The second objective was to determine whether there was any correlation between serum AE and lactonase activities and the various routine liver function tests. The usefulness of adding serum lactonase and AE activity to standard liver function tests was analyzed by multiple logistic regression analysis. Finally, the diagnostic efficacy or analytical performance of AE and lactonase in assessing patients with CLD was determined using 'receiver operating characteristic' (ROC) plot.
Methods: The study group consisted of 120 subjects; 60 were patients with liver disease out of which 40 were having chronic alcoholic liver disease and 20, acute viral hepatitis B, and 60 were healthy controls. Serum PON1 lactonase activity was measured manually using dihydrocoumarin, and AE activity was measured using phenylacetate as substrate. Liver function tests (bilirubin, albumin, AST, ALT, alkaline phosphatise) were done by standard technique.
Result: The serum lactonase and AE activities were decreased significantly in patients with chronic alcoholic liver disease (p < 0.001, p < 0.001) and acute viral hepatitis B (p < 0.001, p < 0.001). Both measurements showed higher efficiency in testing liver dysfunction in multivariate regression analysis. Model 1 consisted of bilirubin, albumin, AST, ALT, and alkaline phosphatase, R2 = 0.912. Model 2 consisted of model 1+arylesterase having higher R2 = 0.0.954, and model 3 consisted of model 1+lactonase having R2 = 0.962. ROC plots demonstrated a high diagnostic accuracy for serum PON1 lactonase (area under ROC curve = 0.982) and serum PON1 arylesterase (area under ROC curve = 0.986).
Conclusion: Low PON1 lactonase and AE activity were found in acute viral hepatitis B and in chronic alcoholic hepatitis.
Similar articles
-
Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.Intern Med J. 2009 Apr;39(4):243-8. doi: 10.1111/j.1445-5994.2009.01793.x. Intern Med J. 2009. PMID: 19402863
-
Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.World J Gastroenterol. 2005 Dec 14;11(46):7351-4. doi: 10.3748/wjg.v11.i46.7351. World J Gastroenterol. 2005. PMID: 16437641 Free PMC article.
-
Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.Br J Nutr. 2016 Feb 28;115(4):730-6. doi: 10.1017/S0007114515004985. Epub 2016 Jan 15. Br J Nutr. 2016. PMID: 26769660
-
Correlation of serum arylesterase activity on phenylacetate estimated by the integrated method to common classical biochemical indexes of liver damage.J Zhejiang Univ Sci B. 2007 Apr;8(4):237-41. doi: 10.1631/jzus.2007.B0237. J Zhejiang Univ Sci B. 2007. PMID: 17444597 Free PMC article.
-
Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.Clin Biochem. 2009 Sep;42(13-14):1394-400. doi: 10.1016/j.clinbiochem.2009.06.007. Epub 2009 Jun 16. Clin Biochem. 2009. PMID: 19538950
Cited by
-
Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma.Meta Gene. 2013 Oct 28;1:93-101. doi: 10.1016/j.mgene.2013.09.007. eCollection 2013 Dec. Meta Gene. 2013. PMID: 25606379 Free PMC article.
-
Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.Cell Cycle. 2019 Sep;18(18):2239-2254. doi: 10.1080/15384101.2019.1642067. Epub 2019 Aug 5. Cell Cycle. 2019. Retraction in: Cell Cycle. 2023 Mar-Mar;22(6):735. doi: 10.1080/15384101.2023.2171195 PMID: 31378124 Free PMC article. Retracted.
-
Association of Paraoxonase 1 Gene Polymorphisms With the Risk of Hepatitis B Virus-related Liver Diseases in a Guangxi Population: A Case-control Study.Medicine (Baltimore). 2015 Dec;94(48):e2179. doi: 10.1097/MD.0000000000002179. Medicine (Baltimore). 2015. PMID: 26632904 Free PMC article.
-
Impacts on Sirtuin Function and Bioavailability of the Dietary Bioactive Compound Dihydrocoumarin.PLoS One. 2016 Feb 16;11(2):e0149207. doi: 10.1371/journal.pone.0149207. eCollection 2016. PLoS One. 2016. PMID: 26882112 Free PMC article.
-
A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.OMICS. 2021 Jan;25(1):38-51. doi: 10.1089/omi.2020.0160. Epub 2020 Dec 11. OMICS. 2021. PMID: 33306925 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous